RHCO yields 6666.67% · PFE yields 6.13%● Live data
📍 RHCO pulled ahead of the other in Year 1
Combined, RHCO + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RHCO + PFE for your $10,000?
Readen Holding Corp., through its subsidiaries, operates in the telecommunications, on line music and video, and recycling industries in the Netherlands and internationally. It engages in the purchase and production-planning, and the communication with hardware and application developers; purchases and distributes plastic products used in the recycling industry; owns a hotel and estates; sells and markets labels, prepaid vouchers, and simcards, as well as engages in physical and electronic distribution via terminals to retailers and distributors; and delivers glassfiber, Internet, VoIP, mobile, TVIP, PoIP, AoIP, and online services in the cloud and e-view managed energy. The company also offers glassfiber networks on an open bases for active operators and service providers; provides online music records that are distributed as MP3 files; engages in ship management and supply; trades in non-dairy products; produces and distributes a range of infant milk formulas; and supplies stable isotopes, deuterated solvents, and high purity materials for medical and chemical research. Readen Holding Corp is headquartered in Kortenhoef, the Netherlands.
Full RHCO Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.